{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:02:12Z","timestamp":1787004132292,"version":"build-2736575974"},"reference-count":139,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":546,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["rsc.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The haem biosynthetic pathway is of fundamental importance for cellular metabolism both for the erythroid and nonerythroid tissues. There are several genetic variants of the pathway in the human population that cause dysfunction of one or other of the enzymes resulting in porphyrias of varying severity. Serious chronic hepatic and systemic diseases may result. Some of these can be precipitated by exposure to drugs including hormones, barbiturates and antibiotics, as well as alcohol and particular chlorinated aromatic chemicals. In experimental animals some of the steps of this pathway can also be severely disrupted by a variety of environmental chemicals, potential drugs and pesticides, especially in the liver, leading to the accumulation of uroporphyrins derived from the intermediate uroporphyrinogens or protoporphyrin IX, the immediate precursor of haem. With some of these chemicals this also leads to cholestasis and liver cell injury and eventually hepatic tumours. The review evaluates the available evidence linking hepatic porphyria with carcinogenesis in naturally occurring human genetic conditions and in chemically-induced porphyrias in laboratory animals. The existing data showing gender, strain, and species differences in sensitivity to the chemical-induced porphyrias, liver injury and liver tumours are discussed and the role that transgenically altered mouse models have played in defining the varying mechanisms. Finally, the review proposes a novel, unifying hypothesis linking the hepatotoxicity induced by the accumulation of various porphyrins, with the increased risk of developing hepatic cancer as a long term consequence.<\/jats:p>","DOI":"10.1039\/c8tx00019k","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T05:27:12Z","timestamp":1527830832000},"page":"647-663","update-policy":"https:\/\/doi.org\/10.1039\/rsc_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The association between chemical-induced porphyria and hepatic cancer"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4823-5656","authenticated-orcid":false,"given":"Andrew G.","family":"Smith","sequence":"first","affiliation":[{"name":"MRC Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE2 4UA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Foster","sequence":"additional","affiliation":[{"name":"ToxPath Sciences Ltd, 1 Troutbeck Avenue, Congleton, Cheshire, CW12 4JA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"2021031806404458800_cit1","first-page":"37","article-title":"Environmental chemical exposures and disturbances of heme synthesis","volume":"105","author":"Daniell","year":"1997","journal-title":"Environ. Health Perspect."},{"key":"2021031806404458800_cit2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/y95-234","article-title":"Cytochrome P450 and its interactions with the heme biosynthetic pathway","volume":"74","author":"De Matteis","year":"1996","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"2021031806404458800_cit3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/tx900298k","article-title":"Complex gene-chemical interactions: hepatic uroporphyria as a paradigm","volume":"23","author":"Smith","year":"2010","journal-title":"Chem. Research Toxicol."},{"key":"2021031806404458800_cit4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1039\/C5TX00011D","article-title":"Complicity of haem in some adverse drug-reactions","author":"Vagany","year":"2015","journal-title":"Toxicol. Res."},{"key":"2021031806404458800_cit5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clinre.2015.05.009","article-title":"Porphyrias: A 2015 update","volume":"39","author":"Karim","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"2021031806404458800_cit6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"2021031806404458800_cit7","first-page":"290","article-title":"Incidence of hepatoma in porphyria cutanea tarda","volume":"8","author":"Berman","year":"1962","journal-title":"Rev. Czech. Med."},{"key":"2021031806404458800_cit8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/bjc.1986.159","article-title":"Porphyrias, porphyrins and hepatocellular cancer","volume":"54","author":"Bengtsson","year":"1986","journal-title":"Br. J. Cancer"},{"key":"2021031806404458800_cit9","first-page":"271","article-title":"Hepatocellular carcinoma in patients with acute intermittent porphyria","volume":"21","author":"Lithner","year":"1984","journal-title":"Acta Med. Scand."},{"key":"2021031806404458800_cit10","first-page":"135","article-title":"Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up","volume":"19","author":"Kordac","year":"1972","journal-title":"Neoplasia"},{"key":"2021031806404458800_cit11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(04)15646-8","article-title":"Liver transplantation as a cure for acute intermittent porphyria","volume":"363","author":"Soonawalla","year":"2004","journal-title":"Lancet"},{"key":"2021031806404458800_cit12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjmed.2014.10.026","article-title":"Role of delta-aminolevulinic acid in the symptoms of acute porphyria","volume":"128","author":"Bissell","year":"2015","journal-title":"Am. J. Med."},{"key":"2021031806404458800_cit13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14218\/JCTH.2014.00039","article-title":"Acute hepatic porphyria","volume":"3","author":"Bissell","year":"2015","journal-title":"J. Clin. Transl. Hepatol."},{"key":"2021031806404458800_cit14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/bjc.1988.23","article-title":"Acute hepatic porphyria and hepatocellular carcinoma","volume":"57","author":"Kauppinen","year":"1988","journal-title":"Br. J. Cancer"},{"key":"2021031806404458800_cit15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2133.1989.tb15519.x","article-title":"Variegate porphyria associated with hepatocellular carcinoma","volume":"121","author":"Tidman","year":"1989","journal-title":"Br. J. Dermatol."},{"key":"2021031806404458800_cit16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0168-8278(00)80097-5","article-title":"Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors","volume":"32","author":"Andant","year":"2000","journal-title":"J. Hepatol."},{"key":"2021031806404458800_cit17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2340\/00015555-0870","article-title":"Hepatocellular carcinoma in variegate porphyria: A serious complication","volume":"90","author":"Schneider-Yin","year":"2010","journal-title":"Acta Derm.-Venereol."},{"key":"2021031806404458800_cit18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2796.2010.02335.x","article-title":"Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden","volume":"26","author":"Innala","year":"2011","journal-title":"J. Intern. Med."},{"key":"2021031806404458800_cit19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10545-012-9576-9","article-title":"High risk of primary liver cancer in a cohort of 179 patients with acute hepatic porphyria","author":"Sardh","year":"2013","journal-title":"J. Inherited Metab. Dis."},{"key":"2021031806404458800_cit20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/joim.12646","article-title":"Acute hepatic porphyria and cancer risk: a nationwide cohort study","volume":"282","author":"Baravelli","year":"2017","journal-title":"J. Intern. Med."},{"key":"2021031806404458800_cit21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2014.11.029","article-title":"Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias","volume":"62","author":"Schneider-Yin","year":"2015","journal-title":"J. Hepatol."},{"key":"2021031806404458800_cit22","first-page":"17","article-title":"Is 5-aminolevulinic acid involved in the hepatocellular carcinogenesis of acute intermittent porphyria?","volume":"48","author":"Onuki","year":"2002","journal-title":"Cell. Mol. Biol."},{"key":"2021031806404458800_cit23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2796.2011.02358.x","article-title":"Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa","volume":"269","author":"Deybach","year":"2011","journal-title":"J. Intern. Med."},{"key":"2021031806404458800_cit24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(96)09436-6","article-title":"Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda","volume":"349","author":"Roberts","year":"1997","journal-title":"Lancet"},{"key":"2021031806404458800_cit25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2559.1980.tb02942.x","article-title":"The pathology of the liver in porphyria cutanea tarda","volume":"4","author":"Cortes","year":"1980","journal-title":"Histopathology"},{"key":"2021031806404458800_cit26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0168-8278(85)80746-7","article-title":"Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors","volume":"1","author":"Salata","year":"1985","journal-title":"J. Hepatol."},{"key":"2021031806404458800_cit27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0676.1992.tb00557.x","article-title":"Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence","volume":"12","author":"Siersema","year":"1992","journal-title":"Liver"},{"key":"2021031806404458800_cit28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0020-711X(80)90179-2","article-title":"Porphyria cutanea tarda and hepatocellular carcinoma","volume":"12","author":"Topi","year":"1980","journal-title":"Int. J. Biochem."},{"key":"2021031806404458800_cit29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/01.meg.0000108318.52416.c9","article-title":"Hepatocellular carcinoma risk in patients with porphyria cutanea tarda","volume":"16","author":"Gisbert","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"2021031806404458800_cit30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0168-8278(01)00160-X","article-title":"Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease","volume":"35","author":"Fracanzani","year":"2001","journal-title":"J. Hepatol."},{"key":"2021031806404458800_cit31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1749-6632.1987.tb48792.x","article-title":"Porphyria cutanea-tarda - manifestation and therapy","volume":"514","author":"Kordac","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2021031806404458800_cit32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ng0296-195","article-title":"Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria","volume":"12","author":"Lindberg","year":"1996","journal-title":"Nat. Genet."},{"key":"2021031806404458800_cit33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cell.2005.06.040","article-title":"Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha","volume":"122","author":"Handschin","year":"2005","journal-title":"Cell"},{"key":"2021031806404458800_cit34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0014-5793(88)80449-6","article-title":"Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase","volume":"233","author":"Francis","year":"1988","journal-title":"FEBS Lett."},{"key":"2021031806404458800_cit35","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2021031806404458800_cit36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/toxsci\/kfl055","article-title":"The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds","volume":"93","author":"Van den Berg","year":"2006","journal-title":"Toxicol. Sci."},{"key":"2021031806404458800_cit37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1289\/ehp.106-1533492","article-title":"Hexachlorobenzene as a possible major contributor to the dioxin activity of human milk","volume":"106","author":"van Birgelen","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"2021031806404458800_cit38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/bj2540245","article-title":"The role of the Ah locus in hexachlorobenzene-induced porphyria, Studies in congenic C57BL\/6J mice","volume":"254","author":"Hahn","year":"1988","journal-title":"Biochem. J."},{"key":"2021031806404458800_cit39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0003-9861(89)90037-4","article-title":"Interaction of hexachlorobenzene with the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro and in vivo. Evidence that hexachlorobenzene is a weak Ah receptor agonist","volume":"270","author":"Hahn","year":"1989","journal-title":"Arch. Biochem. Biophys."},{"key":"2021031806404458800_cit40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008571-199812000-00005","article-title":"Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism: a model of sporadic porphyria cutanea tarda","volume":"8","author":"Akhtar","year":"1998","journal-title":"Pharmacogenetics"},{"key":"2021031806404458800_cit41","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/0006-2952(75)90382-2","article-title":"Mixed type hepatic microsomal enzyme induction by hexachlorobenzene","volume":"24","author":"Stonard","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"2021031806404458800_cit42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0009-2797(76)90141-1","article-title":"Different patterns of hepatic microsomal-enzyme activity produced by administration of pure hexachlorobiphenyl isomers and hexachlorobenzene","volume":"15","author":"Stonard","year":"1976","journal-title":"Chem.-Biol. Interact."},{"key":"2021031806404458800_cit43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jbt.2570010111","article-title":"Distinction between octachlorostyrene and hexachlorobenzene in their potentials to induce ethoxyphenoxazone deethylase and cause porphyria in rats and mice","volume":"1","author":"Smith","year":"1986","journal-title":"J. Biochem. Toxicol."},{"key":"2021031806404458800_cit44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0300-483X(87)90019-9","article-title":"Comparison of hexachlorobenzene-induced alterations of microsomal membrane composition and monooxygenase activity in male and female rats","volume":"45","author":"Cantoni","year":"1987","journal-title":"Toxicology"},{"key":"2021031806404458800_cit45","first-page":"159","article-title":"Effects of hexachlorobenzene on liver porphyrin levels and microsomal enzymes in the rat","volume":"4","author":"Grant","year":"1974","journal-title":"Environ. Physiol. Biochem."},{"key":"2021031806404458800_cit46","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/0006-2952(90)90236-E","article-title":"Sex-linked hepatic uroporphyria and the induction of cytochromes P450IA in rats caused by hexachlorobenzene and polyhalogenated biphenyls","volume":"40","author":"Smith","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"2021031806404458800_cit47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/carcin\/6.4.631","article-title":"Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria","volume":"6","author":"Smith","year":"1985","journal-title":"Carcinogenesis"},{"key":"2021031806404458800_cit48","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0278-6915(85)90278-9","article-title":"et al., Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary vitamin A","volume":"23","author":"Arnold","year":"1985","journal-title":"Food Chem. Toxicol."},{"key":"2021031806404458800_cit49","first-page":"417","article-title":"Oncogenicity of hexachlorobenzene","volume":"77","author":"Erturk","year":"1986","journal-title":"IARC Sci. Publ."},{"key":"2021031806404458800_cit50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1289\/ehp.856097","article-title":"induction of hepatocellular carcinoma in the Sprague-Dawley rat","volume":"60","author":"Norback","year":"1985","journal-title":"Environ. Health Perspect."},{"key":"2021031806404458800_cit51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1289\/ehp.7823265","article-title":"Persistent liver lesions in rats after a single oral dose of polybrominated biphenyls (firemaster FF-1) and concomitant PBB tissue levels","volume":"23","author":"Kimbrough","year":"1978","journal-title":"Environ. Health Perspect."},{"key":"2021031806404458800_cit52","first-page":"535","article-title":"Induction of liver tumors in female Sherman strain rats by polybrominated biphenyls","volume":"66","author":"Kimbrough","year":"1981","journal-title":"J. Natl. Cancer Inst."},{"key":"2021031806404458800_cit53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0041-008X(78)90075-3","article-title":"Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats","volume":"46","author":"Kociba","year":"1978","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021031806404458800_cit54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jat.2550140610","article-title":"Pathological mechanisms of hepatic tumour formation in rats exposed chronically to dietary hexachlorobenzene","volume":"14","author":"Carthew","year":"1994","journal-title":"J. Appl. Toxicol."},{"key":"2021031806404458800_cit55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10408444.2013.835787","article-title":"Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study","volume":"44","author":"Budinsky","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"2021031806404458800_cit56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yrtph.2015.06.015","article-title":"The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor","volume":"73","author":"Becker","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"2021031806404458800_cit57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/toxsci\/kfu065","article-title":"Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF\/IL-1 receptors","volume":"140","author":"Kennedy","year":"2014","journal-title":"Toxicol. Sci."},{"key":"2021031806404458800_cit58","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/carcin\/10.7.1225","article-title":"Hexachlorobenzene as a promoter of diethylnitrosamine-initiated hepatocarcinogenesis in rats and comparison with induction of porphyria","volume":"10","author":"Stewart","year":"1989","journal-title":"Carcinogenesis"},{"key":"2021031806404458800_cit59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0009-2797(79)90138-8","article-title":"A difference between two strains of rats in their liver non-haem iron content and in their response to the porphyrogenic effect of hexachlorobenzene","volume":"27","author":"Smith","year":"1979","journal-title":"Chem.-Biol. Interact."},{"key":"2021031806404458800_cit60","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/carcin\/14.7.1381","article-title":"Enhancement by iron of hepatic neoplasia in rats caused by hexachlorobenzene","volume":"14","author":"Smith","year":"1993","journal-title":"Carcinogenesis"},{"key":"2021031806404458800_cit61","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1042\/bj2140909","article-title":"Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice","volume":"214","author":"Smith","year":"1983","journal-title":"Biochem. J."},{"key":"2021031806404458800_cit62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0041-008X(84)90265-5","article-title":"Incomplete correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity with Ah phenotype in mice","volume":"74","author":"Greig","year":"1984","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021031806404458800_cit63","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.61.3.674","article-title":"Non-ahr gene susceptibility loci for porphyria and liver injury induced by the interaction of \u2018dioxin\u2019 with iron overload in mice","volume":"61","author":"Robinson","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"2021031806404458800_cit64","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ijc.2910430325","article-title":"Carcinogenicity of iron in conjunction with a chlorinated environmental chemical, hexachlorobenzene, in C57BL\/10ScSn mice","volume":"43","author":"Smith","year":"1989","journal-title":"Int. J. Cancer"},{"key":"2021031806404458800_cit65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/carcin\/11.3.437","article-title":"Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL\/10ScSn mice","volume":"11","author":"Smith","year":"1990","journal-title":"Carcinogenesis"},{"key":"2021031806404458800_cit66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/taap.2001.9167","article-title":"Protection of the Cyp1a2(-\/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"173","author":"Smith","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021031806404458800_cit67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/taap.1999.8832","article-title":"CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron","volume":"162","author":"Sinclair","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021031806404458800_cit68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbrc.2005.03.136","article-title":"Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-\/-) knockout mouse","volume":"331","author":"Greaves","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021031806404458800_cit69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3835(94)90195-3","article-title":"Influence of iron on the induction of hepatic tumors and porphyria by octachlorostyrene in C57BL\/10ScSn mice","volume":"81","author":"Smith","year":"1994","journal-title":"Cancer Lett."},{"key":"2021031806404458800_cit70","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/carcin\/16.4.719","article-title":"Perturbation of hepatocyte nuclear populations induced by iron and polychlorinated biphenyls in C57BL\/10ScSn mice during carcinogenesis","volume":"16","author":"Madra","year":"1995","journal-title":"Carcinogenesis"},{"key":"2021031806404458800_cit71","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/carcin\/13.10.1917","article-title":"Search for Ha-ras codon 61 mutations in liver tumours caused by hexachlorobenzene and Aroclor 1254 in C57BL\/10ScSn mice with iron overload","volume":"13","author":"Rumsby","year":"1992","journal-title":"Carcinogenesis"},{"key":"2021031806404458800_cit72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/carcin\/13.2.247","article-title":"Induction of 8-hydroxydeoxyguanosine in Ah-responsive mouse liver by iron and Aroclor 1254","volume":"13","author":"Faux","year":"1992","journal-title":"Carcinogenesis"},{"key":"2021031806404458800_cit73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/mutage\/15.5.379","article-title":"Mutation frequency in the lacI gene of liver DNA from lambda\/lacI transgenic mice following the interaction of PCBs with iron causing hepatic cancer and porphyria","volume":"15","author":"Davies","year":"2000","journal-title":"Mutagenesis"},{"key":"2021031806404458800_cit74","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/B978-0-12-374367-1.00081-1","article-title":"Protoporphyrinogen oxidase-inhibiting herbicides","volume-title":"Hayes Handbook of Pesticide Toxicology","author":"Dayan","year":"2010"},{"key":"2021031806404458800_cit75","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0278-6915(94)90008-6","article-title":"Effect of the protoporphyrinogen oxidase-inhibiting herbicide fomesafen on liver uroporphyrin and heptacarboxylic porphyrin in two mouse strains","volume":"32","author":"Krijt","year":"1994","journal-title":"Food Chem. Toxicol."},{"key":"2021031806404458800_cit76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0041-008X(03)00087-5","article-title":"Experimental hepatic uroporphyria induced by the diphenyl-ether herbicide fomesafen in male DBA\/2 mice","volume":"189","author":"Krijt","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021031806404458800_cit77","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1191\/096032799678840129","article-title":"Liver preneoplastic changes in mice treated with the herbicide fomesafen","volume":"18","author":"Krijt","year":"1999","journal-title":"Hum. Exp. Toxicol."},{"key":"2021031806404458800_cit78","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/jpet.115.228130","article-title":"Protoporphyrin IX: the good, the bad, and the ugly","volume":"356","author":"Sachar","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021031806404458800_cit79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-5793(80)81009-X","article-title":"Conversion of liver haem into N-substituted porphyrins or green pigments. Nature of the substituent at the pyrrole nitrogen atom","volume":"119","author":"De Matteis","year":"1980","journal-title":"FEBS Lett."},{"key":"2021031806404458800_cit80","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/0049825021000012637","article-title":"Comparison of rat and human cytochrome P450 (CYP) sources of N-alkylprotoporphyrin IX. Formation after interaction with porphyrinogenic xenobiotics: studies with cDNA-expressed single CYP enzymes","volume":"32","author":"Gamble","year":"2002","journal-title":"Xenobiotica"},{"key":"2021031806404458800_cit81","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1139\/y00-030","article-title":"Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes","volume":"78","author":"Gamble","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"2021031806404458800_cit82","first-page":"923","article-title":"The origin of the increased protoporphyrin in erythrocytes of mice with experimentally induced porphyria","volume":"70","author":"Nakao","year":"1967","journal-title":"J. Lab. Clin. Med."},{"key":"2021031806404458800_cit83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jbt.2570050307","article-title":"Strain and sex differences in the response of mice to drugs that induce protoporphyria: role of porphyrin biosynthesis and removal","volume":"5","author":"Holley","year":"1990","journal-title":"J. Biochem. Toxicol."},{"key":"2021031806404458800_cit84","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0014-5793(81)80194-9","article-title":"Liver production of N-alkylated porphyrins caused in mice by treatment with substituted dihydropyridines. Evidence that the alkyl group on the pyrrole nitrogen atom originates from the drug","volume":"129","author":"De Matteis","year":"1981","journal-title":"FEBS Lett."},{"key":"2021031806404458800_cit85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/bj1460285","article-title":"Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-diethoxycarbonyl-1,4-dihydrocollidine and related drugs: evidence for two basically different mechanisms","volume":"146","author":"De Matteis","year":"1975","journal-title":"Biochem. J."},{"key":"2021031806404458800_cit86","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1289\/ehp.111-1241506","article-title":"Gene expression profiles associated with inflammation, fibrosis, and cholestasis in mouse liver after griseofulvin","volume":"111","author":"Gant","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"2021031806404458800_cit87","first-page":"83","article-title":"Experimental porphyria induced by (3-(2,4,6-trimethylphenyl)-thioethyl)-4 methylsydnone","volume":"18","author":"Stejskal","year":"1975","journal-title":"Virchows Arch. B"},{"key":"2021031806404458800_cit88","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0300-483X(93)90117-B","article-title":"Effects of 2-[1-(ethoxyimino)propyl]-3-hydroxy-5-(2,4,6-trimethylphenyl) cyclohex-2-enone on hepatic haem biosynthesis: species differences in hepatic porphyria","volume":"84","author":"Brady","year":"1993","journal-title":"Toxicology"},{"key":"2021031806404458800_cit89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01973305","article-title":"Formation of N-methyl protoporphyrin in chemically-induced protoporphyria. Studies with a novel porphyrogenic agent","volume":"67","author":"Frater","year":"1993","journal-title":"Arch. Toxicol."},{"key":"2021031806404458800_cit90","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/bj1890645","article-title":"Inhibition of protohaem ferro-lyase by N-substituted porphyrins. Structural requirements for the inhibitory effect","volume":"189","author":"De Matteis","year":"1980","journal-title":"Biochem. J."},{"key":"2021031806404458800_cit91","first-page":"119","article-title":"Substrate-dependent irreversible inactivation of cytochrome P-450: conversion of its haem moiety into modified porphyrins","volume":"76","author":"De Matteis","year":"1980","journal-title":"Ciba Found. Symp."},{"key":"2021031806404458800_cit92","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/bj1960575","article-title":"Destruction of liver haem by norethindrone. Conversion into green pigments","volume":"196","author":"White","year":"1981","journal-title":"Biochem. J."},{"key":"2021031806404458800_cit93","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10408449709078444","article-title":"Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment","volume":"27","author":"Knasmuller","year":"1997","journal-title":"Crit. Rev. Toxicol."},{"key":"2021031806404458800_cit94","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/toxsci\/kfu131","article-title":"N-alkylprotoporphyrin formation and hepatic porphyria in dogs after administration of a new antiepileptic drug candidate: Mechanism and species specificity","volume":"141","author":"Nicolas","year":"2014","journal-title":"Toxicol. Sci."},{"key":"2021031806404458800_cit95","first-page":"721","article-title":"The effects of prolonged administration of griseofulvin in mice with reference to sex differences","volume":"26","author":"De Matteis","year":"1966","journal-title":"Cancer Res."},{"key":"2021031806404458800_cit96","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jcp.27.9.698","article-title":"A light and electron microscopic study of the liver in case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice","volume":"27","author":"Matilla","year":"1974","journal-title":"J. Clin. Pathol."},{"key":"2021031806404458800_cit97","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/1523-1747.ep12598357","article-title":"Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals","volume":"65","author":"Gschnait","year":"1975","journal-title":"J. Invest. Dermatol."},{"key":"2021031806404458800_cit98","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3346\/jkms.1991.6.2.146","article-title":"Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin","volume":"6","author":"Choi","year":"1991","journal-title":"J. Korean Med. Sci."},{"key":"2021031806404458800_cit99","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1897\/03-536.1","article-title":"Hepatic porphyria induced by the herbicide tralkoxydim in small mammals is species-specific","volume":"24","author":"Pauli","year":"2005","journal-title":"Environ. Toxicol. Chem."},{"key":"2021031806404458800_cit100","first-page":"1","article-title":"Conclusion on the peer review of the pesticide risk assessment of the active substance Tralkoxydim","volume":"139","author":"EFSA Report","year":"2008","journal-title":"EFSA J."},{"key":"2021031806404458800_cit101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-5793(82)81212-X","article-title":"Inactivation of cytochrome P-450 and production of N-alkylated porphyrins caused in isolated hepatocytes by substituted dihydropyridines. Structural requirements for loss of haem and alkylation of the pyrrole nitrogen atom","volume":"145","author":"de Matteis","year":"1982","journal-title":"FEBS Lett."},{"key":"2021031806404458800_cit102","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01974011","article-title":"Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals","volume":"66","author":"Brady","year":"1992","journal-title":"Arch. Toxicol."},{"key":"2021031806404458800_cit103","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/bcp.12178","article-title":"Risk of oral antifungal agent-induced liver injury in Taiwanese","volume":"77","author":"Kao","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2021031806404458800_cit104","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(63)92989-1","article-title":"Griseofulvin administration and porphyrin metabolism. A survey","volume":"2","author":"Rimington","year":"1963","journal-title":"Lancet"},{"key":"2021031806404458800_cit105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jama.1965.03080240075027","article-title":"Precipitation of acute intermittent porphyria by griseofulvin therapy","volume":"192","author":"Berman","year":"1965","journal-title":"J. Am. Med. Assoc."},{"key":"2021031806404458800_cit106","first-page":"127","article-title":"Hepatic damage and oxidative stress induced by griseofulvin in mice","volume":"55","author":"Martinez Mdel","year":"2009","journal-title":"Cell Mol. Biol."},{"key":"2021031806404458800_cit107","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0016-5085(81)90123-2","article-title":"Bile acids modify alkaline phosphatase induction and bile secretion pressure after bile duct obstruction in the rat","volume":"80","author":"Hatoff","year":"1981","journal-title":"Gastroenterology"},{"key":"2021031806404458800_cit108","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.1963.tb13946.x","article-title":"Protoporphyrin, cirrhosis and hepatomata in the livers of mice given griseofulvin","volume":"75","author":"Weston-Hurst","year":"1963","journal-title":"Br. J. Dermatol."},{"key":"2021031806404458800_cit109","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/bjc.1978.194","article-title":"Thyroid tumours in rats and hepatomas in mice after griseofulvin treatment","volume":"38","author":"Rustia","year":"1978","journal-title":"Br. J. Cancer"},{"key":"2021031806404458800_cit110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-3623(96)00406-5","article-title":"Griseofulvin-induced hepatopathy due to abnormalities in heme pathway","volume":"29","author":"Polo","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"2021031806404458800_cit111","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.1987.tb48770.x","article-title":"Biochemical studies on griseofulvin-induced protoporphyria","volume":"514","author":"Shimoyama","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2021031806404458800_cit112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1346-8138.1984.tb01440.x","article-title":"A biochemical study of experimental porphyria. I. The influence of griseofulvin at various concentrations on porphyrin metabolism","volume":"11","author":"Shimoyama","year":"1984","journal-title":"J. Dermatol."},{"key":"2021031806404458800_cit113","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1172\/JCI115491","article-title":"Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease","volume":"88","author":"Tutois","year":"1991","journal-title":"J. Clin. Invest."},{"key":"2021031806404458800_cit114","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0002-9440(10)62325-5","article-title":"Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool","volume":"166","author":"Davies","year":"2005","journal-title":"Am. J. Pathol."},{"key":"2021031806404458800_cit115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.1257","article-title":"Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria","volume":"199","author":"Libbrecht","year":"2003","journal-title":"J. Pathol."},{"key":"2021031806404458800_cit116","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1242\/dmm.027755","article-title":"Modeling the ferrochelatase c.315\u201348C modifier mutation for erythropoietic protoporphyria (EPP) in mice","volume":"10","author":"Barman-Aksozen","year":"2017","journal-title":"Dis. Models & Mech."},{"key":"2021031806404458800_cit117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-4-19","article-title":"Erythropoietic protoporphyria","volume":"4","author":"Lecha","year":"2009","journal-title":"Orphanet. J. Rare Dis."},{"key":"2021031806404458800_cit118","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1182\/blood-2010-11-319483","article-title":"Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria","volume":"117","author":"Troadec","year":"2011","journal-title":"Blood"},{"key":"2021031806404458800_cit119","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2014.03.032","article-title":"Acute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse model","volume":"51","author":"Homedan","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2021031806404458800_cit120","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1093\/hmg\/ddi410","article-title":"Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice","volume":"14","author":"Thierbach","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"2021031806404458800_cit121","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/10408390903110692","article-title":"The Key Events Dose-Response Framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds","volume":"49","author":"Julien","year":"2009","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"Suppl. 3","key":"2021031806404458800_cit122","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10408444.2014.931925","article-title":"The use of mode of action information in risk assessment: quantitative key events\/dose-response framework for modeling the dose-response for key events","volume":"44","author":"Simon","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"2021031806404458800_cit123","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.2204108","article-title":"Cell proliferation in carcinogenesis","volume":"249","author":"Cohen","year":"1990","journal-title":"Science"},{"key":"2021031806404458800_cit124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0021-9975(97)80071-0","article-title":"The role of cell proliferation in chemically induced carcinogenesis","volume":"116","author":"Foster","year":"1997","journal-title":"J. Comp. Pathol."},{"key":"2021031806404458800_cit125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/toxsci\/kfj001","article-title":"Mode of action in relevance of rodent liver tumors to human cancer risk","volume":"89","author":"Holsapple","year":"2006","journal-title":"Toxicol. Sci."},{"key":"2021031806404458800_cit126","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ijc.2910190207","article-title":"Long-term administration of DDT or phenobarbital-Na in Wistar rats","volume":"19","author":"Rossi","year":"1977","journal-title":"Int. J. Cancer"},{"key":"2021031806404458800_cit127","first-page":"3919","article-title":"Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats","volume":"53","author":"Greaves","year":"1993","journal-title":"Cancer Res."},{"key":"2021031806404458800_cit128","first-page":"1133","article-title":"Effect of age and sex on hepatic lesions in Buffalo strain rats ingesting diethylnitrosamine","volume":"41","author":"Reuber","year":"1968","journal-title":"J. Natl. Cancer Inst."},{"key":"2021031806404458800_cit129","first-page":"814","article-title":"A sex difference in the development of liver tumors in rats fed 3\u2032-methyl-4-dimethylaminoazobenzene or 4\u2032-fluoro-4-dimethylaminoazobenzene","volume":"11","author":"Rumsfeld Jr.","year":"1951","journal-title":"Cancer Res."},{"key":"2021031806404458800_cit130","first-page":"2370","article-title":"Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat","volume":"27","author":"Wogan","year":"1967","journal-title":"Cancer Res."},{"key":"2021031806404458800_cit131","first-page":"151","article-title":"Sex difference in liver tumorgenesis in rats ingesting N-2-fluorenylacetamide","volume":"26","author":"Sidransky","year":"1961","journal-title":"J. Natl. Cancer Inst."},{"key":"2021031806404458800_cit132","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-5793(82)81212-X","article-title":"Inactivation of cytochrome P-450 and production of porphyrins caused in isolated hepatocytes by substituted dihydropyridines. Structural requirements for the loss of haem and alkylation of the pyrrole nitrogen atom","volume":"145","author":"De Matteis","year":"1982","journal-title":"FEBS Lett."},{"key":"2021031806404458800_cit133","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/bj2460221","article-title":"Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload","volume":"246","author":"Smith","year":"1987","journal-title":"Biochem. J."},{"key":"2021031806404458800_cit134","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/0006-2952(81)90421-4","article-title":"Hepatic toxicity and uroporphyrinogen decarboxylase activity following a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin to mice","volume":"30","author":"Smith","year":"1981","journal-title":"Biochem. Pharmacol."},{"key":"2021031806404458800_cit135","first-page":"9050713","article-title":"Lead poisoning can be easily misdiagnosed as acute porphyria and nonspecific abdominal pain","author":"Tsai","year":"2017","journal-title":"Case Rep. Emerg. Med."},{"key":"2021031806404458800_cit136","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type 1 by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"key":"2021031806404458800_cit137","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0022-3476(76)80259-4","article-title":"The occurrence of hepatoma in the chronic form of hereditary tyrosinemia","volume":"88","author":"Weinberg","year":"1976","journal-title":"J. Pediatr."},{"key":"2021031806404458800_cit138","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.bbadis.2015.09.002","article-title":"Molecular changes associated with chronic liver damage and neoplatic lesions in a murine model of hereditary tyrosinemia type1","volume":"1852","author":"Angileri","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"2021031806404458800_cit139","first-page":"169","article-title":"Porphyrias caused by chlorinated AH receptor ligands and associated mechanisms of liver injury and cancer","volume-title":"The Porphyrin Handbook, Vol 14, Medical aspects of porphyrins","author":"Smith","year":"2003"}],"container-title":["Toxicology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxres\/article-pdf\/7\/4\/647\/36632223\/toxres_7_4_647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/toxres\/article-pdf\/7\/4\/647\/36632223\/toxres_7_4_647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T02:44:54Z","timestamp":1616035494000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxres\/article\/7\/4\/647\/5555801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":139,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,6,1]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1039\/c8tx00019k","relation":{},"ISSN":["2045-4538"],"issn-type":[{"value":"2045-4538","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"This document is Similarity Check deposited","name":"similarity_check","explanation":{"URL":"https:\/\/www.crossref.org\/services\/similarity-check\/"},"group":{"name":"similarity_check","label":"SIMILARITY CHECK"}},{"value":"Andrew G. Smith (ORCID)","URL":"http:\/\/orcid.org\/0000-0002-4823-5656","name":"identifier","group":{"name":"author_identifiers","label":"IDENTIFIERS"}},{"value":"Single-blind","order":2,"name":"peer_review_method","group":{"name":"peer_review_method","label":"PEER REVIEW METHOD"}},{"value":"Received 12 January 2018; Accepted 4 April 2018; Advance Article published 1 June 2018; Version of Record published 2 July 2018","order":1,"name":"history","group":{"name":"publication_history","label":"PUBLICATION HISTORY"}}]}}